Three-year follow-up after pCAD-POAF
Official title: Partial Cardiac Denervation to Prevent POAF After CABG: 3 Year Follow-up of pCAD-POAF Randomized Trial
Run by China National Center for Cardiovascular Diseases · NCT07146061 · Data updated 2026-11-12
This study follows people who were in the pCAD-POAF trial to see how they’re doing three years after their surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 430 (estimated) |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | August 15, 2025 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07146061 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Individuals who previously enrolled in the pCAD-POAF trial and completed the initial study are eligible for the follow-up.
✕Probably not a fit
Patients who did not participate in the original pCAD-POAF trial or who are not available for long-term follow-up may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, non-interventional follow-up of participants from the pCAD-POAF trial. Researchers will track outcomes for three years after surgery, including a composite of death, stroke, embolism, heart attack, unplanned rehospitalization, or post-discharge atrial fibrillation. Secondary outcomes include individual components, arrhythmias, heart rhythm and rate measures, quality of life, and Holter-derived data. At the 3-year visit, participants will undergo tests such as labs, ECG, and echocardiography, with optional CT angiography and continuous arrhythmia monitoring. No further treatments will be administered as part of this follow-up.
Why it matters
Potential benefit: Participants may gain a better understanding of long-term risks and health trajectories after pCAD-POAF, which could inform future care.
How similar studies have gone: Other post-trial observational follow-ups have shown value in understanding long-term outcomes after cardiovascular procedures, though this exact design is specific to the pCAD-POAF cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * This study will include the subjects who enrolled in pCAD-POAF trial Exclusion Criteria: * This study will include the subjects who enrolled in pCAD-POAF trial
Where it's running
-
Fuwai Hospital, CAMS & PUMC
Beijing, China Recruiting
Study contacts
- Principal investigator: Wei Feng, MD — Chinese Academy of Medical Sciences, Fuwai Hospital
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DOACs: continue or pause around elective heart artery procedures
This study tests whether continuing DOAC blood thinners during elective coronary angiography or PCI is safe for adults with atrial fibrillation and coronary artery disease.
-
Registry for monitoring heart conditions
This study is collecting health information from people with heart symptoms to see if it can help doctors catch heart problems earlier and understand them better.
-
Optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI
This study is testing whether a new blood-thinning treatment for patients with atrial fibrillation undergoing heart procedures is safer and just as effective as the traditional approach that includes more medications.
-
Investigating surgical techniques to reduce stroke risk during heart surgery
This study is testing whether certain surgical techniques during heart surgery can help reduce the risk of stroke and new heart rhythm problems in patients having bypass surgery.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.